$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Role of interferons in SLE

Best practice & research. Clinical rheumatology, v.31 no.3, 2017년, pp.415 - 428  

Bengtsson, Anders A. (Lund University, Skå) ,  Rönnblom, Lars (ne University Hospital, Department of Clinical Sciences Lund, Rheumatology, 22185 Lund, Sweden)

Abstract AI-Helper 아이콘AI-Helper

Abstract Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that affects many different organ systems, with excessive production of type I interferons (IFNs) and autoantibodies against nucleic acids as hallmarks. Activation of the type I IFN system in SLE is due to cont...

주제어

참고문헌 (98)

  1. Trends Immunol Ronnblom 22 8 427 2001 10.1016/S1471-4906(01)01955-X An etiopathogenic role for the type I IFN system in SLE 

  2. Semin Immunol Ronnblom 23 2 113 2011 10.1016/j.smim.2011.01.009 The type I interferon system in the development of lupus 

  3. Autoimmun Rev Smith 10 1 43 2010 10.1016/j.autrev.2010.08.016 Systemic lupus erythematosus: clinical presentations 

  4. N. Engl J Med Tsokos 365 22 2110 2011 10.1056/NEJMra1100359 Systemic lupus erythematosus 

  5. Transl Res J Lab Clin Med Crow 165 2 296 2015 Targeting of type I interferon in systemic autoimmune diseases 

  6. Autoimmun Rev Yaniv 14 1 75 2015 10.1016/j.autrev.2014.10.003 A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients 

  7. N. Engl J Med Arbuckle 349 16 1526 2003 10.1056/NEJMoa021933 Development of autoantibodies before the clinical onset of systemic lupus erythematosus 

  8. Autoimmun Rev Agmon-Levin 11 8 593 2012 10.1016/j.autrev.2011.10.020 Systemic lupus erythematosus one disease or many? 

  9. J Exp Med Bennett 197 6 711 2003 10.1084/jem.20021553 Interferon and granulopoiesis signatures in systemic lupus erythematosus blood 

  10. Curr Opin Rheumatol Crow 26 5 467 2014 10.1097/BOR.0000000000000087 Advances in understanding the role of type I interferons in systemic lupus erythematosus 

  11. Curr Opin Rheumatol Ronnblom 25 2 248 2013 10.1097/BOR.0b013e32835c7e32 The interferon signature in autoimmune diseases 

  12. Nature Bialas 546 7659 539 2017 10.1038/nature22821 Microglia-dependent synapse loss in type I interferon-mediated lupus 

  13. Trends Microbiol Gurtler 21 8 413 2013 10.1016/j.tim.2013.04.004 Innate immune detection of microbial nucleic acids 

  14. Nat Immunol Kawai 11 5 373 2010 10.1038/ni.1863 The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors 

  15. EMBO J Rigby 33 6 542 2014 10.1002/embj.201386117 RNA: DNA hybrids are a novel molecular pattern sensed by TLR9 

  16. Biochimie Fitzgerald-Bocarsly 89 6-7 843 2007 10.1016/j.biochi.2007.04.018 The role of type I interferon production by dendritic cells in host defense 

  17. Nat Rev Immunol Swiecki 15 8 471 2015 10.1038/nri3865 The multifaceted biology of plasmacytoid dendritic cells 

  18. Science Liu 347 6227 aaa2630 2015 10.1126/science.aaa2630 Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation 

  19. Annu Rev Immunol Wu 32 461 2014 10.1146/annurev-immunol-032713-120156 Innate immune sensing and signaling of cytosolic nucleic acids 

  20. J Immunol Bave 171 6 3296 2003 10.4049/jimmunol.171.6.3296 Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG 

  21. Arthritis Rheum Lovgren 54 6 1917 2006 10.1002/art.21893 Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA 

  22. Autoimmun Rev Pinegin 14 7 633 2015 10.1016/j.autrev.2015.03.002 Neutrophil extracellular traps and their role in the development of chronic inflammation and autoimmunity 

  23. Proc Natl Acad Sci U S A Hakkim 107 21 9813 2010 10.1073/pnas.0909927107 Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis 

  24. Arthritis Res Ther Leffler 17 205 2015 10.1186/s13075-015-0726-y A subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources 

  25. Sci Transl Med Garcia-Romo 3 73 73ra20 2011 10.1126/scitranslmed.3001201 Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus 

  26. J Exp Med Caielli 213 5 697 2016 10.1084/jem.20151876 Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus 

  27. Nat Med Lood 22 2 146 2016 10.1038/nm.4027 Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease 

  28. Arthritis Rheumatol Mavragani 68 11 2686 2016 10.1002/art.39795 Expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease 

  29. Annu Rev Immunol Schneider 32 513 2014 10.1146/annurev-immunol-032713-120231 Interferon-stimulated genes: a complex web of host defenses 

  30. Trends Immunol Hoffmann 36 3 124 2015 10.1016/j.it.2015.01.004 Interferons and viruses: an evolutionary arms race of molecular interactions 

  31. Nat Rev Immunol Platanias 5 5 375 2005 10.1038/nri1604 Mechanisms of type-I- and type-II-interferon-mediated signalling 

  32. Lupus Barbhaiya 23 6 588 2014 10.1177/0961203314530488 Ultraviolet radiation and systemic lupus erythematosus 

  33. Semin Immunopathol Kuhn 38 1 97 2016 10.1007/s00281-015-0550-0 Lupus erythematosus revisited 

  34. Nat Immunol Wack 16 8 802 2015 10.1038/ni.3212 Guarding the frontiers: the biology of type III interferons 

  35. J Invest Dermatol Zahn 131 1 133 2011 10.1038/jid.2010.244 Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNlambda) in cutaneous lupus erythematosus 

  36. J Biol Chem Kemp 290 19 12184 2015 10.1074/jbc.M115.649301 UV light potentiates STING (stimulator of interferon genes)-dependent innate immune signaling through deregulation of ULK1 (Unc51-like kinase 1) 

  37. Expert Opin Drug Saf Rubin 14 3 361 2015 10.1517/14740338.2015.995089 Drug-induced lupus 

  38. Nat Rev Mol Cell Biol Biggar 16 1 5 2015 10.1038/nrm3915 Non-histone protein methylation as a regulator of cellular signalling and function 

  39. Arthritis Rheum Deapen 35 3 311 1992 10.1002/art.1780350310 A revised estimate of twin concordance in systemic lupus erythematosus 

  40. Nat Genet Bentham 47 12 1457 2015 10.1038/ng.3434 Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus 

  41. J Autoimmun Cui 41 25 2013 10.1016/j.jaut.2013.01.008 Genetic susceptibility to SLE: recent progress from GWAS 

  42. Curr Opin Rheumatol Deng 26 5 482 2014 10.1097/BOR.0000000000000086 Advances in lupus genetics and epigenetics 

  43. Curr Opin Rheumatol Chen 29 5 423 2017 10.1097/BOR.0000000000000411 Genetic advances in systemic lupus erythematosus: an update 

  44. Curr Opin Immunol Bronson 24 5 530 2012 10.1016/j.coi.2012.07.008 The genetics of type I interferon in systemic lupus erythematosus 

  45. Arthritis Rheum Niewold 58 8 2481 2008 10.1002/art.23613 Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients 

  46. Hum Mol Genet Berggren 24 12 3571 2015 10.1093/hmg/ddv095 IFN-alpha production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases 

  47. PLoS One Bolin 8 12 e84450 2013 10.1371/journal.pone.0084450 Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis 

  48. Arthritis Rheum Crow 63 12 3661 2011 10.1002/art.30603 Lupus: how much “complexity” is really (just) genetic heterogeneity? 

  49. Hum Mol Genet Sigurdsson 17 18 2868 2008 10.1093/hmg/ddn184 A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5 

  50. Ann Rheum Dis Svenungsson 69 5 834 2010 10.1136/ard.2009.115535 A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus 

  51. Ann Rheum Dis Olsson 2017 10.1136/annrheumdis-2017-211287 A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus 

  52. Nat Genet Zhao 49 3 433 2017 10.1038/ng.3782 A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases 

  53. Proc Natl Acad Sci U S A Jacob 109 2 E59 2012 10.1073/pnas.1113251108 Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase 

  54. Antioxidants Redox Signal Kelkka 21 16 2231 2014 10.1089/ars.2013.5828 Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature 

  55. Curr Opin Immunol Elkon 24 6 665 2012 10.1016/j.coi.2012.08.004 Complement, interferon and lupus 

  56. Nat Genet Lee-Kirsch 39 9 1065 2007 10.1038/ng2091 Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus 

  57. Arthritis Rheum Lood 60 10 3081 2009 10.1002/art.24852 C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis 

  58. J Immunol Santer 185 8 4738 2010 10.4049/jimmunol.1001731 C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes 

  59. J Interferon Cytokine Res Offic J Int Soc Interferon Cytokine Res Hertzog 31 1 5 2011 10.1089/jir.2010.0126 Systems biology of interferon responses 

  60. Nat Rev Immunol Gonzalez-Navajas 12 2 125 2012 10.1038/nri3133 Immunomodulatory functions of type I interferons 

  61. Trends Immunol Schreiber 36 3 139 2015 10.1016/j.it.2015.01.002 The molecular basis for functional plasticity in type I interferon signaling 

  62. Nat Rev Immunol McNab 15 2 87 2015 10.1038/nri3787 Type I interferons in infectious disease 

  63. Trends Mol Med Grammatikos 18 2 101 2012 10.1016/j.molmed.2011.10.005 Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus 

  64. Arthritis Rheum Eloranta 65 4 853 2013 10.1002/art.37821 Disease mechanisms in rheumatology-tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases 

  65. Clin Dev Immunol Alunno 2012 823085 2012 10.1155/2012/823085 Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new 

  66. Curr Opin Immunol Jackson 33 70 2015 10.1016/j.coi.2015.01.018 B cells take the front seat: dysregulated B cell signals orchestrate loss of tolerance and autoantibody production 

  67. Sci Rep Lopez 6 20651 2016 10.1038/srep20651 A pathogenic IFNalpha, BLyS and IL-17 axis in systemic lupus erythematosus patients 

  68. Cytokine Vazquez 74 2 318 2015 10.1016/j.cyto.2015.02.007 B cells responses and cytokine production are regulated by their immune microenvironment 

  69. Arthritis Rheum Thacker 64 9 2975 2012 10.1002/art.34504 Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis 

  70. Curr Opin Rheumatol Knight 25 5 597 2013 10.1097/BOR.0b013e328363eba3 Cardiovascular disease in lupus: insights and updates 

  71. J Interferon Cytokine Res Official J Int Soc Interferon Cytokine Res Savan 34 5 318 2014 10.1089/jir.2013.0117 Post-transcriptional regulation of interferons and their signaling pathways 

  72. Immunol Rev Swiecki 234 1 142 2010 10.1111/j.0105-2896.2009.00881.x Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance 

  73. Arthritis Rheum Eloranta 60 8 2418 2009 10.1002/art.24686 Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells 

  74. Arthritis Rheum Berggren 64 10 3409 2012 10.1002/art.34599 B lymphocytes enhance interferon-alpha production by plasmacytoid dendritic cells 

  75. Ann Rheum Dis Leonard 75 9 1728 2016 10.1136/annrheumdis-2015-208055 Activated T cells enhance interferon-alpha production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes 

  76. J Immunol Hagberg 186 9 5085 2011 10.4049/jimmunol.1003349 IFN-alpha production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1beta and LFA-1 

  77. Life Sci Privratsky 87 3-4 69 2010 10.1016/j.lfs.2010.06.001 PECAM-1: conflicts of interest in inflammation 

  78. J Autoimmun Clement 56 23 2015 10.1016/j.jaut.2014.09.002 Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo 

  79. Sci Transl Med Duffau 2 47 47ra63 2010 10.1126/scitranslmed.3001001 Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus 

  80. Blood Lood 116 11 1951 2010 10.1182/blood-2010-03-274605 Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease 

  81. Clin Transl Immunol Oon 5 5 e79 2016 10.1038/cti.2016.26 Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway 

  82. Arthritis Rheumatol Furumoto 69 1 148 2017 10.1002/art.39818 Tofacitinib ameliorates murine lupus and its associated vascular dysfunction 

  83. Ann Rheum Dis Khamashta 75 11 1909 2016 10.1136/annrheumdis-2015-208562 Sifalimumab, an anti-interferon-alpha monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study 

  84. Ann Rheum Dis Kalunian 75 1 196 2016 10.1136/annrheumdis-2014-206090 A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE) 

  85. Arthritis Rheumatol Furie 69 2 376 2017 10.1002/art.39962 Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus 

  86. J Immunol Sun 190 6 2536 2013 10.4049/jimmunol.1202689 Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice 

  87. Arthritis Rheum Martin 68 Suppl 10 2016 BIIB059, an anti-BDCA2 monoclonal antibody, demonstrates acceptable safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects in a phase 1 study with single ascending doses (SAD) in healthy volunteers 

  88. EMBO Mol Med Pellerin 7 4 464 2015 10.15252/emmm.201404719 Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms 

  89. Arthritis Rheum Ichikawa 64 2 493 2012 10.1002/art.33333 Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells 

  90. Nat Immunol Volkman 15 5 415 2014 10.1038/ni.2872 The enemy within: endogenous retroelements and autoimmune disease 

  91. Arthritis Rheum Furie 63 12 3918 2011 10.1002/art.30613 A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus 

  92. Lancet Navarra 377 9767 721 2011 10.1016/S0140-6736(10)61354-2 Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial 

  93. Arthritis Res Ther Yao 12 Suppl 1 S6 2010 10.1186/ar2887 Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNalpha antibody, in systemic lupus erythematosus 

  94. Lupus Bengtsson 9 9 664 2000 10.1191/096120300674499064 Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies 

  95. J Exp Med Rodero 214 5 1547 2017 10.1084/jem.20161451 Detection of interferon alpha protein reveals differential levels and cellular sources in disease 

  96. Proc Natl Acad Sci U S A Baechler 100 5 2610 2003 10.1073/pnas.0337679100 Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus 

  97. Ann Rheum Dis Landolt-Marticorena 68 9 1440 2009 10.1136/ard.2008.093146 Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus 

  98. J Mol Med Strauss 95 7 753 2017 10.1007/s00109-017-1515-7 Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options 

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로